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The  alterations  in  the hemostatic mechanism  with  two intravenous  injec- 
tions of bacterial endotoxin indicate that the generalized  Shwartzman reaction 
is,  in essence,  two episodes  of disseminated intravascular  coagulation  (1,  2). 
This  view  is  considerably  strengthened  by  the  observations  of  Good  and 
Thomas (3), and Cluff and Berthrong (4), that heparin prevents the generalized 
as well as the localized Shwartzman reaction. Since the major action of heparin 
is  anticoagulant  (presumably  antithrombic  and  antithromboplastic),  it  is 
probably by this mechanism that heparin prevents the Shwartzman reaction. 
However,  another  interpretation  of  the  action  of  heparin  has  been  pre- 
sented by Thomas (5). This author has suggested that the injection of endo- 
toxin releases an "acid polysaccharide" which combines directly with fibrinogen 
causing  the precipitation  of fibrinogen  and its deposition in the small  vessels 
of the circulation.  It has been further postulated that  the preventive action 
of heparin  is a preferential binding of heparin  with fibrinogen  to prevent the 
combination of "acid polysaccharide" with fibrinogen. 
The question is therefore raised as to whether the clotting mechanism,  prior 
to the stage of polymerization of fibrinogen  to fibrin,  is involved in this reac- 
tion.  One  means  of  answering  this  question  would  be  to  remove  the 
prothrombin-complex from the circulation  of the rabbits and  then  challenge 
the  dotting mechanism  with  endotoxin.  If thrombosis were to occur in  the 
absence of the prothrombin complex the problem would remain,  but if thrombo- 
sis  did  not  occur in  the  absence  of  the  prothrombin  complex,  the  clotting 
mechanism would be implicated in this reaction. 
Experiments are available from the literature on the effect of hypoprothrom- 
binemic drugs on the Shwartzman  reaction  (6-8). But, because these experi- 
ments have been concerned  only with the localized  reaction and are further- 
more contradictory, the following studies using sodium warfarin as the hypo- 
prothrombinemic agent and Shear's polysacCharide  as the Shwartzman-active 
agent are reported. 
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Materials and Methods 
Sodium warfarin,  1 an intravenous hypoprothrorabinemic drug related to 4-hydroxycouma- 
rin, was administered to 1 kg. rabbits ~a the marginal ear vein according  to the following 
schedule :- 
An initial dose of 30 rag. was given on the 1st day, followed by daily doses of 15 rag. for 
4 days. On the 4th day 0.2 rag. of Shear's polysaccharide was injected intravenously, followed 
in 24 hours by another intravenous injection of 0.2 rag. of Shear's polysaccharide and 7.5 rag. 
of sodium warfarin. The following day blood was drawn by cardiac puncture on all surviving 
animals and one stage prothrombin tiraes (and in some cases, whole blood coagulation times 
in uncoated glass) were done. The animals were sacrificed and autopsied; the tissues fixed in 
10 per cent formalin and paraffin sections stained with hematoxylin and eosin. Eighteen ani- 
mals were used in the test series and 7 in the control series. The latter group were injected 
intravenously with 2 doses of 0.2 rag. of Shear's polysaccharide, 24 hours apart. 
TABLE I 
E~t of Sodium Warfarin on Rabbit Prott~ombin Times 
Vaiues in seconds 
Rabbit  Day 1  Day 2  Day 3  Day 4 
A-1 
A-2 
A-3 
A-5 
A-6 
A-7 
A-8 
A-9 
A-10 
7.8 
7.8 
7.6 
6.9 
7.6 
7.9 
8.4 
9.4 
8.6 
50.0* 
41 
28.5 
> 120 
51.5 
25.1 
43.2 
> 120" 
43.3 
> 120" 
20.7* 
47.8 
>  120 
>120" 
* Died as a result of cardiac puncture. 
Effect  of Sodium  Warfarin  on  Rabbits'  Blood.--Initially  it  was  hoped  to 
follow  the  process  of  anticoagulation  in  the  rabbits  by  daily prothrombin 
time. Because  cardiac puncture  was  used  to obtain the blood,  the mortality 
in a  group  of  9  animals was  prohibitive. However,  the  observations on  this 
group,  presented  in  Table  I,  indicate  a  marked  inhibition  of  prothrombin 
activity in a  relatively short period of time. 
Although  there  was  variability in  response  to  the  sodium  warfarin,  the 
majority  of  animals  developed  a  significantly prolonged  prothrombin  time 
by  the  3rd  or 4th  day of  administration.  Because  of  the  high  mortality in 
this group,  and  because it had  been  shown  previously (1)  that  prothrombin 
times are not altered by production of the generalized Shwartzman reaction, 
the  prothrombin  determinations  in  the  experimental  group  were  omitted 
until the day the animal was sacrificed. 
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Prevention  of the  Generalized Shwartzman  Reaction.--Of  the  18 animals  in 
the  experimental  group  exposed to  two intravenous  injections  of endotoxin 
following warfarin pretreatment,  only 9 survived the period of time required 
for  the  development of  the generalized  Shwartzman  reaction.  As shown  in 
Table  H,  none  of  these  animals  developed bilateral  renal  cortical  necrosis 
nor were any histologic  thrombi found anywhere in the viscera. 
In contrast to this group, in a  control series treated  only with endotoxin, 
6  of  7 rabbits  developed bilateral  renal  cortical  necrosis.  The  remaining  9 
animals of the experimental group died at varying periods of time during the 
48 hours of exposure to endotoxin.  None of these animals showed renal lesions, 
and only one showed any microscopic  thrombi and these were few in number. 
Since it has been shown that  one injection of toxin produces thrombi in the 
TABLE  II 
Effect of Sodium Warfarin on t~e Shwartzman Reaction 
Rabbit  Prothrombin  Whole blood  Renal cortical  Histologie 
,  time  coagulation time  necrosis  thrombi 
B-1 
B-2 
B-3 
B-4 
B-12 
B-13 
B-18 
B-19 
B -20 
Sf,  C. 
29 
>  120 
>  120 
32 
43 
> 120 
46 
> 120 
> 120 
mln. 
>120 
> 120 
>120 
> 120 
spleen,  liver, and  lungs  in  many  animals,  the  preventive  action  of  sodium 
warfarin  applies  also  to  the  less extensive thrombosis after one injection as 
well as to the fully developed Shwartzman reaction. 
DISCUSSION 
Thomas and coworkers (9) were able to demonstrate the appearance of an 
altered form of fibrinogen  in the blood of endotoxin-treated rabbits. Ricketts 
and Walton  (10-13)  had previously shown that high molecular weight acidic 
polysaccharides,  of the general class of dextran sulfates, are capable of precipi- 
tating fibrinogen  directly in vitro, and of producing lesions in animals  similar 
to, if not identical with, those of the generalized  Shwartzman reaction.  Using 
these facts, Thomas et al.  (5, 14) showed a synergism between high molecular 
weight dextran  sulfates and  endotoxin,  in  the production of the generalized 
Shwartzman  reaction. Thus they concluded that  the preparatory injection of 
endotoxin results in the production of a high molecular weight acidic polysac- 380  SHWARTZMAN  REACTION  PREVENTED  BY  SODIUM  WARFARIN 
charide,  reaching  optimal concentrations at the time of the provocative injec- 
tion,  and  combining  with  the altered fibrinogen  produced by the endotoxin. 
Heparin would then prevent the Shwartzman reaction by combining preferen- 
tially with fibrinogen  at the expense of the acid polysaccharide. 
On the other hand,  the data presented here indicate quite clearly that  the 
prothrombin  complex  is  necessary  for  the  elicitation  of  the  characteristic 
pathologic lesions of the generalized  Shwartzman  reaction. 
In the light of this fact, the concept of a direct fibrinogen-precipitating  mech- 
anism must be modified. It is well known that almost any mechanism resulting 
in fibrin  deposition may start  the  cyclic activity of the coagulation  system. 
Perhaps in the Shwartzman reaction the primary event actually is fibrinogen 
precipitation  by a  circulating  "acidic polysaccharide,"  as  Thomas  suggests; 
this,  of  itself,  is  not  enough,  apparently,  to  produce  the  characteristic 
pathologic lesions, were it not for the subsequent recruitment of the "classical" 
clotting mechanism. 
Thus,  one is led to the concept that  the generalized  Shwartzman  reaction 
involves an episode of diffuse  intravascular  coagulation,  which,  regardless  of 
the initiating stimulus, requires for its completion the participation of the en- 
tire clotting mechanism. 
SUMMARY  AND  CONCLUSIONS 
Using intravenous  sodium warfarin,  rabbits were rendered  hypoprothrom- 
binemic and subjected to two intravenous injections of Shear's polysaccharide. 
None of the 9 animals surviving the required period of time developed bilateral 
renal  cortical  necrosis  or histologic  thrombi  in  the kidney,  liver,  spleen,  or 
lungs. In a control group of 7 animals treated only with endotoxin,  6 developed 
bilateral renal cortical necrosis. 
It is concluded that the prothrombin complex is necessary for the production 
of the generalized  Shwartzman reaction by bacterial endotoxins and that this 
phenomenon is essentially a process of disseminated intravascular coagulation. 
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